`

Sonoma Biotherapeutics

Biotechnology Research

Specialities :
Cell therapy and autoimmune disease
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$30.0M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Sonoma Biotherapeutics

What does Sonoma biotherapeutics do?+

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle

What are Sonoma biotherapeutics's specialties? +

Cell therapy and autoimmune disease

What is Sonoma biotherapeutics's industry? +

Sonoma biotherapeutics operates in the Biotechnology research industry.

What is Sonoma biotherapeutics's revenue? +

Sonoma biotherapeutics's revenue is 11m - 100m

What is Sonoma biotherapeutics's company size? +

Sonoma biotherapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free